Vitura Health (ASX:VIT) EBIT per Share: A$0.00 (TTM As of Dec. 2025)


What is Vitura Health EBIT per Share?

Vitura Health ASX:VIT EBIT per Share is A$0.00 as of Dec. 2025. The stock has 8 warning signs investors should review. Among 810 Drug Manufacturers companies, Vitura Health ranks worse than 85.68% on this metric.

Vitura Health's EBIT per Share for the six months ended in Dec. 2025 was A$0.00. Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 was A$0.00.

During the past 12 months, the average EBIT per Share Growth Rate of Vitura Health was -50.00% per year. During the past 3 years, the average EBIT per Share Growth Rate was -22.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Vitura Health's EBIT per Share or its related term are showing as below:

ASX:VIT' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -22   Med: -22   Max: -22
Current: -22

During the past 7 years, the highest 3-Year average EBIT per Share Growth Rate of Vitura Health was -22.00% per year. The lowest was -22.00% per year. And the median was -22.00% per year.

ASX:VIT's 3-Year EBIT Growth Rate is ranked worse than
85.68% of 810 companies
in the Drug Manufacturers industry
Industry Median: 7.55 vs ASX:VIT: -22.00

Vitura Health's EBIT for the six months ended in Dec. 2025 was A$-0.1 Mil.

Vitura Health  (ASX:VIT) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Vitura Health EBIT per Share Related Terms

Vitura Health EBIT per Share Historical Data

* Premium members only.

The historical data trend for Vitura Health's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vitura Health EBIT per Share Chart

Vitura Health Annual Data
Trend Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
EBIT per Share
Get a 7-Day Free Trial -0.03 0.02 0.04 0.01 0.01

Vitura Health Semi-Annual Data
Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EBIT per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.00 0.01 0.00 0.00

Vitura Health EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Vitura Health's EBIT per Share for the fiscal year that ended in Jun. 2025 is calculated as

EBIT per Share(A: Jun. 2025 )
=EBIT/Shares Outstanding (Diluted Average)
=5.562/609.878
=0.01

Vitura Health's EBIT per Share for the quarter that ended in Dec. 2025 is calculated as

EBIT per Share(Q: Dec. 2025 )
=EBIT/Shares Outstanding (Diluted Average)
=-0.063/662.498
=-0.00

EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT per Share →
What does a EBIT per Share of A$0.00 mean?
Vitura Health (ASX:VIT) has a EBIT per Share of A$0.00 as of Dec. 2025. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Vitura Health and its competitors. According to the industry distribution chart, Vitura Health ranks #694 out of 810 companies in the Drug Manufacturers industry, placing it in the top 85.7%.
Is Vitura Health's EBIT per Share too high?
Vitura Health's current EBIT per Share is A$0.00. Based on the distribution chart, Vitura Health ranks #694 out of 810 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does Vitura Health's EBIT per Share compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Vitura Health ranks #694 out of 810 companies for EBIT per Share. This places Vitura Health in the lower half of its industry. The industry median EBIT per Share is 7.55. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Drug Manufacturers company?
The median EBIT per Share among Drug Manufacturers companies is 7.55, based on 810 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Vitura Health and its competitors. For the Drug Manufacturers industry, the median EBIT per Share is 7.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vitura Health's current EBIT per Share is A$0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vitura Health stock overvalued right now?
Based on GuruFocus' analysis, Vitura Health (ASX:VIT) is currently considered Significantly Undervalued. The stock's GF Value™ is A$0.10, compared to a current price of A$0.03 — trading 73% below its estimated fair value. The current EBIT per Share is A$0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Vitura Health (ASX:VIT), the current EBIT per Share is A$0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Vitura Health Business Description

Address 299 Toorak Road, Suite 8, Level 3, South Yarra, VIC, AUS, 3141
Vitura Health Ltd is focused on creating medicinal cannabis products and digital health solutions that connect and strengthen the ecosystem between patients, prescribers, pharmacists, and suppliers. The company has two business segments namely, Sales and distribution (involving the sale and distribution of medical products including medicinal cannabis, psychedelic drugs, and smoking cessation products) and Clinics and services (involving the operation of medicinal cannabis clinics and the provision of related services). The company generates the majority of its revenue from the Sales and distribution segment. Geographically the company generates the majority of its revenue from Australia.